Terms: = Sarcomas AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
168 results:
1. PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC; Chang TC; Wang Y; Guo L; Gao Y; Bikorimana E; Lemoff A; Fang YV; Zhang H; Zhang Y; Ye D; Soria-Bretones I; Servetto A; Lee KM; Luo X; Otto JJ; Akamatsu H; Napolitano F; Mani R; Cescon DW; Xu L; Xie Y; Mendell JT; Hanker AB; Arteaga CL
Nat Commun; 2024 Mar; 15(1):2287. PubMed ID: 38480701
[TBL] [Abstract] [Full Text] [Related]
2. Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma.
Zhang L; Luo L; Liu C; Li Z
Diagn Pathol; 2024 Feb; 19(1):30. PubMed ID: 38347522
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omic and functional analysis for classification and treatment of sarcomas with fus-TFCP2 or EWSR1-TFCP2 fusions.
Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
[TBL] [Abstract] [Full Text] [Related]
4. Neuronal dysfunction caused by fusR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract] [Full Text] [Related]
5. Hyperhidrosis as the initial symptom in fus mutation-associated amyotrophic lateral sclerosis: a case report and comprehensive literature review.
Chen X; Luo J; Zheng W; Huang Q; Du C; Yuan H; Xiao F
Neurol Sci; 2024 Apr; 45(4):1523-1527. PubMed ID: 37904013
[TBL] [Abstract] [Full Text] [Related]
6. lncRNA Sequencing Reveals Neurodegeneration-Associated fus Mutations Alter Transcriptional Landscape of iPS Cells That Persists in Motor Neurons.
Provasek VE; Kodavati M; Guo W; Wang H; Boldogh I; Van Den Bosch L; Britz G; Hegde ML
Cells; 2023 Oct; 12(20):. PubMed ID: 37887305
[TBL] [Abstract] [Full Text] [Related]
7. Drosha-dependent microRNAs modulate fus-mediated neurodegeneration in vivo.
Kour S; Fortuna T; Anderson EN; Mawrie D; Bilstein J; Sivasubramanian R; Ward C; Roy R; Rajasundaram D; Sterneckert J; Pandey UB
Nucleic Acids Res; 2023 Nov; 51(20):11258-11276. PubMed ID: 37791873
[TBL] [Abstract] [Full Text] [Related]
8. Intraosseous Spindle Cell Rhabdomyosarcoma with
Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
[TBL] [Abstract] [Full Text] [Related]
9. First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma.
Benitez-Escobar EN; Galindes-Casanova DA; Melo-Burbano LÁ; Bonilla-Bonilla DM; Osorio-Toro LM; Daza-Arana JE; Escobar-Dávila SL; Rivas-Tafurt GP
Chin Clin Oncol; 2023 Aug; 12(4):45. PubMed ID: 37599513
[TBL] [Abstract] [Full Text] [Related]
10. IFNγ protects motor neurons from oxidative stress via enhanced global protein synthesis in fus-associated amyotrophic lateral sclerosis.
Assoni AF; Guerrero EN; Wardenaar R; Oliveira D; Bakker PL; Alves LM; Carvalho VM; Okamoto OK; Zatz M; Foijer F
Brain Pathol; 2024 Jan; 34(1):e13206. PubMed ID: 37582053
[TBL] [Abstract] [Full Text] [Related]
11. Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.
Bagyinszky E; Hulme J; An SSA
Cells; 2023 Jul; 12(15):. PubMed ID: 37566027
[TBL] [Abstract] [Full Text] [Related]
12. Frontotemporal lobar degeneration.
Grossman M; Seeley WW; Boxer AL; Hillis AE; Knopman DS; Ljubenov PA; Miller B; Piguet O; Rademakers R; Whitwell JL; Zetterberg H; van Swieten JC
Nat Rev Dis Primers; 2023 Aug; 9(1):40. PubMed ID: 37563165
[TBL] [Abstract] [Full Text] [Related]
13. Pancreatic follicular dendritic cell sarcoma: a rare case report and systematic literature review of 7 cases.
Li X; Gu J; He Q; Han S; Wu H
World J Surg Oncol; 2023 Jul; 21(1):212. PubMed ID: 37480085
[TBL] [Abstract] [Full Text] [Related]
14. Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/chop Stress Response Pathway.
Ludwig MP; Galbraith MD; Eduthan NP; Hill AA; Clay MR; Tellez CM; Wilky BA; Elias A; Espinosa JM; Sullivan KD
Cancer Res; 2023 Aug; 83(15):2543-2556. PubMed ID: 37205634
[TBL] [Abstract] [Full Text] [Related]
15. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
Quesada S; Lebreton C; Caux C; Italiano A; Dubois B
Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731
[TBL] [Abstract] [Full Text] [Related]
16. Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes.
Kondo T; Ebinuma I; Tanaka H; Nishikawa Y; Komiya T; Ishikawa M; Okano H
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108151
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
18. Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment.
Cybulska-Stopa B; Piejko K; Ostaszewski K; Dziura R; Galus Ł; Ziółkowska B; Kempa-Kamińska N; Ziętek M; Bal W; Kamycka A; Dudzisz-Śledź M; Kubiatowski T; Kamińska-Winciorek G; Suwiński R; Mackiewicz J; Czarnecka AM; Rutkowski P
Melanoma Res; 2023 Jun; 33(3):208-217. PubMed ID: 37015054
[TBL] [Abstract] [Full Text] [Related]
19. Hypoxia-Induced fus-circTBC1D14 Stress Granules Promote Autophagy in TNBC.
Liu Y; Liu Y; He Y; Zhang N; Zhang S; Li Y; Wang X; Liang Y; Chen X; Zhao W; Chen B; Wang L; Luo D; Yang Q
Adv Sci (Weinh); 2023 Apr; 10(10):e2204988. PubMed ID: 36806670
[TBL] [Abstract] [Full Text] [Related]
20. Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin.
Wei H; Du X; Zhao H; Sun P; Yang J
Int J Clin Pract; 2023; 2023():3093945. PubMed ID: 36756222
[TBL] [Abstract] [Full Text] [Related]
[Next]
